Autres langues Genmab A/S

Actions

Marché Fermé - Nasdaq Copenhagen Autres places de cotation 16:59:46 25/04/2024			Varia. 5j.	Varia. 1 janv.
1 916 ^DKK	-2,87 %		-4,56 %	-11,11 %

04/04	AVIS D'ANALYSTES DU JOUR : BNP Paribas, Renault, Pernod-Ricard, Eurofins, Ferrari, Worldline, Sika, Elior...
03/04	Genmab : l'acquisition de ProfoundBio accueillie sans émotion	CF

Transactions in Connection with Share Buy-back Program Genmab	22/04
Transactions in Connection with Share Buy-back Program Genmab	22/04
Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug	16/04
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024	16/04
Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024	16/04
Transactions in Connection with Share Buy-back Program Genmab	15/04
Health Care Slips on Risk Bias -- Health Care Roundup	11/04
Transactions in Connection with Share Buy-back Program	08/04
OPINIONES DE LOS ANALISTAS DEL DÍA : Adyen, Burberry, Endesa, Ferrari, Genmab, Melia Hotels, Telefónica, Sika..	04/04
Health Care Flat on Rotation to Rate-Sensitive Sectors -- Health Care Roundup	03/04
News Highlights : Top Company News of the Day - Wednesday at 11 AM ET	03/04
ADC oncology acquisition to address solid tumours	03/04
Global markets live: Swiss Re, Intel, Walt Disney, Paramount, Microsoft...	03/04
News Highlights : Top Company News of the Day - Wednesday at 9 AM ET	03/04
Correction to Genmab Article	03/04
Genmab : l'acquisition de ProfoundBio accueillie sans émotion	03/04
News Highlights : Top Company News of the Day - Wednesday at 7 AM ET	03/04
Genmab A/S Re-Affirms Revenue Guidance for the Year 2024	03/04
European Midday Briefing : Stocks Continue to Struggle Despite Cooling Inflation	03/04
News Highlights : Top Company News of the Day - Wednesday at 5 AM ET	03/04

Aucun résultat pour cette recherche

GENMAB : Genmab est disponible à un prix avantageux

Le 04 mars 2024 à 12:10

Genmab, l'autre success-story danoise de la santé